CD13 and ROR2 Permit Isolation of Highly Enriched Cardiac Mesoderm from Differentiating Human Embryonic Stem Cells

Stem Cell Reports

Volumn 6, Issue 1, 2016, Pages 95-108

  Skelton, Rhys J P ^a,b,c   Brady, Bevin ^d   Khoja, Suhail ^a,b   Sahoo, Debashis ^d   Engel, James ^a,b   Arasaratnam, Deevina ^c   Saleh, Kholoud K ^a,b   Abilez, Oscar J ^d   Zhao, Peng ^a,b   Stanley, Edouard G ^c   Elefanty, Andrew G ^c   Kwon, Murray ^a   Elliott, David A ^c   Ardehali, Reza ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; MICROSOMAL AMINOPEPTIDASE; PROTEIN ROR2; UNCLASSIFIED DRUG; RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR; ROR2 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LINEAGE; CELL TRANSPLANTATION; CONTROLLED STUDY; EMBRYO; ENDODERM; ENDOTHELIUM CELL; ENGRAFTMENT; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE ONTOLOGY; HUMAN; HUMAN CELL; HUMAN EMBRYONIC STEM CELL; IN VITRO STUDY; KIDNEY CAPSULE; MESODERM; MESODERMAL CELL; MUSCLE STEM CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; ANIMAL; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY; PIG; PLURIPOTENT STEM CELL; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE; STEM CELL TRANSPLANTATION; TIME FACTOR; XENOGRAFT;

ANIMALS; ANTIGENS, CD13; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; ENDOTHELIAL CELLS; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; HUMAN EMBRYONIC STEM CELLS; HUMANS; MESODERM; MICE; MUSCLE, SMOOTH; MYOCARDIUM; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; SWINE; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84955320203     PISSN: 22136711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stemcr.2015.11.006     Document Type: Article

References (49)

1. A.R. Afzal, A. Rajab, C.D. Fenske, M. Oldridge, N. Elanko, E. Ternes-Pereira, B. Tuysuz, V.A. Murday, M.A. Patton, A.O. Wilkie, and et al. Recessive Robinow syndrome, allelic to dominant brachydactyly type B, is caused by mutation of ROR2 Nat. Genet. 25 2000 419 422
2. S.R. Ali, S. Hippenmeyer, L.V. Saadat, L. Luo, I.L. Weissman, and R. Ardehali Existing cardiomyocytes generate cardiomyocytes at a low rate after birth in mice Proc. Natl. Acad. Sci. USA 111 2014 8850 8855
3. R. Ardehali, S.R. Ali, M.A. Inlay, O.J. Abilez, M.Q. Chen, T.A. Blauwkamp, M. Yazawa, Y. Gong, R. Nusse, M. Drukker, and et al. Prospective isolation of human embryonic stem cell-derived cardiovascular progenitors that integrate into human fetal heart tissue Proc. Natl. Acad. Sci. USA 110 2013 3405 3410
4. K. Ban, B. Wile, S. Kim, H.J. Park, J. Byun, K.W. Cho, T. Saafir, M.K. Song, S.P. Yu, M. Wagner, and et al. Purification of cardiomyocytes from differentiating pluripotent stem cells using molecular beacons that target cardiomyocyte-specific mRNA Circulation 128 2013 1897 1909
5. O. Bergmann, R.D. Bhardwaj, S. Bernard, S. Zdunek, F. Barnabe-Heider, S. Walsh, J. Zupicich, K. Alkass, B.A. Buchholz, H. Druid, and et al. Evidence for cardiomyocyte renewal in humans Science 324 2009 98 102
6. G. Blin, D. Nury, S. Stefanovic, T. Neri, O. Guillevic, B. Brinon, V. Bellamy, C. Rucker-Martin, P. Barbry, A. Bel, and et al. A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates J. Clin. Invest. 120 2010 1125 1139
7. C. Cheung, A.S. Bernardo, R.A. Pedersen, and S. Sinha Directed differentiation of embryonic origin-specific vascular smooth muscle subtypes from human pluripotent stem cells Nat. Protoc. 9 2014 929 938
8. J.J. Chong, X. Yang, C.W. Don, E. Minami, Y.W. Liu, J.J. Weyers, W.M. Mahoney, B. Van Biber, S.M. Cook, N.J. Palpant, and et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts Nature 510 2014 273 277
9. J. Cibelli, M.E. Emborg, D.J. Prockop, M. Roberts, G. Schatten, M. Rao, J. Harding, and O. Mirochnitchenko Strategies for improving animal models for regenerative medicine Cell Stem Cell 12 2013 271 274
10. K.A. D'Amour, A.D. Agulnick, S. Eliazer, O.G. Kelly, E. Kroon, and E.E. Baetge Efficient differentiation of human embryonic stem cells to definitive endoderm Nat. Biotechnol. 23 2005 1534 1541
11. B.I. Dalal, A. Al Mugairi, S. Pi, S.Y. Lee, N.S. Khare, J. Pal, A. Bryant, A.P. Vakil, S. Lau, and Y.R. Abou Mourad Aberrant expression of CD13 identifies a subgroup of standard-risk adult acute lymphoblastic leukemia with inferior survival Clin. Lymphoma Myeloma Leuk. 14 2014 239 244
12. R.P. Davis, E.S. Ng, M. Costa, A.K. Mossman, K. Sourris, A.G. Elefanty, and E.G. Stanley Targeting a GFP reporter gene to the MIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enables isolation of primitive hematopoietic precursors Blood 111 2008 1876 1884
13. S.C. Den Hartogh, C. Schreurs, J.J. Monshouwer-Kloots, R.P. Davis, D.A. Elliott, C.L. Mummery, and R. Passier Dual reporter MESP1 mCherry/w-NKX2-5 eGFP/w hESCs enable studying early human cardiac differentiation Stem Cells 33 2015 56 67
14. M. Drukker, C. Tang, R. Ardehali, Y. Rinkevich, J. Seita, A.S. Lee, A.R. Mosley, I.L. Weissman, and Y. Soen Isolation of primitive endoderm, mesoderm, vascular endothelial and trophoblast progenitors from human pluripotent stem cells Nat. Biotechnol. 30 2012 531 542
15. N.C. Dubois, A.M. Craft, P. Sharma, D.A. Elliott, E.G. Stanley, A.G. Elefanty, A. Gramolini, and G. Keller SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells Nat. Biotechnol. 29 2011 1011 1018
16. D.A. Elliott, S.R. Braam, K. Koutsis, E.S. Ng, R. Jenny, E.L. Lagerqvist, C. Biben, T. Hatzistavrou, C.E. Hirst, Q.C. Yu, and et al. NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes Nat. Methods 8 2011 1037 1040
17. E.H. Estey Acute myeloid leukemia: 2013 update on risk-stratification and management Am. J. Hematol. 88 2013 318 327
18. D. Evseenko, Y. Zhu, K. Schenke-Layland, J. Kuo, B. Latour, S. Ge, J. Scholes, G. Dravid, X. Li, W.R. MacLellan, and et al. Mapping the first stages of mesoderm commitment during differentiation of human embryonic stem cells Proc. Natl. Acad. Sci. USA 107 2010 13742 13747
19. W. Gorczyca, Z.Y. Sun, W. Cronin, X. Li, S. Mau, and S. Tugulea Immunophenotypic pattern of myeloid populations by flow cytometry analysis Methods Cell Biol. 103 2011 221 266
20. F. Hattori, H. Chen, H. Yamashita, S. Tohyama, Y.S. Satoh, S. Yuasa, W. Li, H. Yamakawa, T. Tanaka, T. Onitsuka, and et al. Nongenetic method for purifying stem cell-derived cardiomyocytes Nat. Methods 7 2010 61 66
21. S.J. Kattman, A.D. Witty, M. Gagliardi, N.C. Dubois, M. Niapour, A. Hotta, J. Ellis, and G. Keller Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines Cell Stem Cell 8 2011 228 240
22. H. Kita-Matsuo, M. Barcova, N. Prigozhina, N. Salomonis, K. Wei, J.G. Jacot, B. Nelson, S. Spiering, R. Haverslag, C. Kim, and et al. Lentiviral vectors and protocols for creation of stable hESC lines for fluorescent tracking and drug resistance selection of cardiomyocytes PLoS One 4 2009 e5046
23. M.A. Laflamme, and C.E. Murry Regenerating the heart Nat. Biotechnol. 23 2005 845 856
24. P.A. Lalit, D.J. Hei, A.N. Raval, and T.J. Kamp Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges Circ. Res. 114 2014 1328 1345
25. Z. Li, K.D. Wilson, B. Smith, D.L. Kraft, F. Jia, M. Huang, X. Xie, R.C. Robbins, S.S. Gambhir, I.L. Weissman, and et al. Functional and transcriptional characterization of human embryonic stem cell-derived endothelial cells for treatment of myocardial infarction PLoS One 4 2009 e8443
26. V. Mani, E. Adler, K.C. Briley-Saebo, A. Bystrup, V. Fuster, G. Keller, and Z.A. Fayad Serial in vivo positive contrast MRI of iron oxide-labeled embryonic stem cell-derived cardiac precursor cells in a mouse model of myocardial infarction Magn. Reson. Med. 60 2008 73 81
27. E. Matsa, P.W. Burridge, and J.C. Wu Human stem cells for modeling heart disease and for drug discovery Sci. Transl. Med. 6 2014 239ps236
28. C. Mauritz, A. Martens, S.V. Rojas, T. Schnick, C. Rathert, N. Schecker, S. Menke, S. Glage, R. Zweigerdt, A. Haverich, and et al. Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction Eur. Heart J. 32 2011 2634 2641
29. K.E. McGrath, A.D. Koniski, K.M. Maltby, J.K. McGann, and J. Palis Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4 Dev. Biol. 213 1999 442 456
30. P. Menasche, V. Vanneaux, A. Hagege, A. Bel, B. Cholley, I. Cacciapuoti, A. Parouchev, N. Benhamouda, G. Tachdjian, L. Tosca, and et al. Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report Eur. Heart J. 36 2015 2011 2017
31. Y. Minami, I. Oishi, M. Endo, and M. Nishita Ror-family receptor tyrosine kinases in noncanonical Wnt signaling: their implications in developmental morphogenesis and human diseases Dev. Dyn. 239 2010 1 15
32. F.B. Myers, J.S. Silver, Y. Zhuge, R.E. Beygui, C.K. Zarins, L.P. Lee, and O.J. Abilez Robust pluripotent stem cell expansion and cardiomyocyte differentiation via geometric patterning Integr. Biol. (Camb) 5 2013 1495 1506
33. I. Oishi, H. Suzuki, N. Onishi, R. Takada, S. Kani, B. Ohkawara, I. Koshida, K. Suzuki, G. Yamada, G.C. Schwabe, and et al. The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway Genes Cells 8 2003 645 654
34. Z. Pasha, H. Haider, and M. Ashraf Efficient non-viral reprogramming of myoblasts to stemness with a single small molecule to generate cardiac progenitor cells PLoS One 6 2011 e23667
35. M. Pick, L. Azzola, A. Mossman, E.G. Stanley, and A.G. Elefanty Differentiation of human embryonic stem cells in serum-free medium reveals distinct roles for bone morphogenetic protein 4, vascular endothelial growth factor, stem cell factor, and fibroblast growth factor 2 in hematopoiesis Stem Cells 25 2007 2206 2214
36. Y. Shiba, S. Fernandes, W.Z. Zhu, D. Filice, V. Muskheli, J. Kim, N.J. Palpant, J. Gantz, K.W. Moyes, H. Reinecke, and et al. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts Nature 489 2012 322 325
37. R.J. Skelton, M. Costa, D.J. Anderson, F. Bruveris, B.W. Finnin, K. Koutsis, D. Arasaratnam, A.J. White, A. Rafii, E.S. Ng, and et al. SIRPA, VCAM1 and CD34 identify discrete lineages during early human cardiovascular development Stem Cell Res. 13 2014 172 179
38. T. Stankovicova, M. Szilard, I. De Scheerder, and K.R. Sipido M cells and transmural heterogeneity of action potential configuration in myocytes from the left ventricular wall of the pig heart Cardiovasc. Res. 45 2000 952 960
39. T. Tallheden, U. Nannmark, M. Lorentzon, O. Rakotonirainy, B. Soussi, F. Waagstein, A. Jeppsson, E. Sjogren-Jansson, A. Lindahl, and E. Omerovic In vivo MR imaging of magnetically labeled human embryonic stem cells Life Sci. 79 2006 999 1006
40. M.S. Thu, L.H. Bryant, T. Coppola, E.K. Jordan, M.D. Budde, B.K. Lewis, A. Chaudhry, J. Ren, N.R. Varma, A.S. Arbab, and et al. Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging Nat. Med. 18 2012 463 467
41. H. Uosaki, H. Fukushima, A. Takeuchi, S. Matsuoka, N. Nakatsuji, S. Yamanaka, and J.K. Yamashita Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression PLoS One 6 2011 e23657
42. L.W. van Laake, R. Passier, J. Monshouwer-Kloots, A.J. Verkleij, D.J. Lips, C. Freund, K. den Ouden, D. Ward-van Oostwaard, J. Korving, L.G. Tertoolen, and et al. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction Stem Cell Res. 1 2007 9 24
43. L.W. van Laake, R. Passier, P.A. Doevendans, and C.L. Mummery Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents Circ. Res. 102 2008 1008 1010
44. L.W. van Laake, R. Passier, K. den Ouden, C. Schreurs, J. Monshouwer-Kloots, D. Ward-van Oostwaard, C.J. van Echteld, P.A. Doevendans, and C.L. Mummery Improvement of mouse cardiac function by hESC-derived cardiomyocytes correlates with vascularity but not graft size Stem Cell Res. 3 2009 106 112
45. Q. Xiong, L. Ye, P. Zhang, M. Lepley, C. Swingen, L. Zhang, D.S. Kaufman, and J. Zhang Bioenergetic and functional consequences of cellular therapy: activation of endogenous cardiovascular progenitor cells Circ. Res. 111 2012 455 468
46. L. Yang, M.H. Soonpaa, E.D. Adler, T.K. Roepke, S.J. Kattman, M. Kennedy, E. Henckaerts, K. Bonham, G.W. Abbott, R.M. Linden, and et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population Nature 453 2008 524 528
47. L. Ye, Y.H. Chang, Q. Xiong, P. Zhang, L. Zhang, P. Somasundaram, M. Lepley, C. Swingen, L. Su, J.S. Wendel, and et al. Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells Cell Stem Cell 15 2014 750 761
48. F. Yusuf, R. Rehimi, F. Dai, and B. Brand-Saberi Expression of chemokine receptor CXCR4 during chick embryo development Anat. Embryol. (Berl) 210 2005 35 41
49. X. Zhang, H. Fang, J. Zhang, Y. Yuan, and W. Xu Recent advance in aminopeptidase N (APN/CD13) inhibitor research Curr. Med. Chem. 18 2011 5011 5021